SEC Form 4 · accession 0001104659-19-006336
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Rong Zhou
Officer — EVP, Production Center
Period of report
Feb 5, 2019
Accepted (ET)
Feb 7, 2019 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2019 | M | 3,200 | $20.26 | A | 56,319 | D | |
| Common Stock | Feb 5, 2019 | S | 4,289 | $23.00 | D | 52,030 | D | |
| Common StockF2 | holding | — | — | — | 99,668 | I | See footnote | |
| Common StockF3 | holding | — | — | — | 5,000 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $20.26 | Feb 5, 2019 | M | 3,200 | D | — | Aug 5, 2019 | Common Stock | 3,200 | 12,800 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2018.
- F2The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.
- F3The shares are held of record by the reporting person's spouse.
- F4Shares subject to the option are fully vested and immediately exercisable.
Remarks
Exhibit 24 - Power of Attorney